Dr. Kathryn M. Leininger
Claim this profileCleveland Clinic Akron General
Studies Cancer
Studies Lung Cancer
16 reported clinical trials
34 drugs studied
Area of expertise
1Cancer
Stage III
Stage II
Stage I
2Lung Cancer
Stage III
Stage II
Stage I
Affiliated Hospitals
Cleveland Clinic Akron General
Clinical Trials Kathryn M. Leininger is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Kathryn M. Leininger
Clinical Trial Related4 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Kathryn M. Leininger has experience with
- Biospecimen Collection
- Fluorouracil
- Oxaliplatin
- Questionnaire Administration
- Pembrolizumab
- Paclitaxel
Breakdown of trials Kathryn M. Leininger has run
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kathryn M. Leininger specialize in?
Kathryn M. Leininger focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage III patients, or patients who are Stage II.
Is Kathryn M. Leininger currently recruiting for clinical trials?
Yes, Kathryn M. Leininger is currently recruiting for 8 clinical trials in Akron Ohio. If you're interested in participating, you should apply.
Are there any treatments that Kathryn M. Leininger has studied deeply?
Yes, Kathryn M. Leininger has studied treatments such as Biospecimen Collection, Fluorouracil, Oxaliplatin.
What is the best way to schedule an appointment with Kathryn M. Leininger?
Apply for one of the trials that Kathryn M. Leininger is conducting.
What is the office address of Kathryn M. Leininger?
The office of Kathryn M. Leininger is located at: Cleveland Clinic Akron General, Akron, Ohio 44307 United States. This is the address for their practice at the Cleveland Clinic Akron General.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.